Jinyu Bio-Technology Co Ltd

Pharmaceuticals

Company Summary

Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary vaccines in China. The company offers vaccines for reproductive and respiratory syndrome, heat-resistant, parvovirus inactivated, erysipelas, paratyphoid, colibacillosis, circovirus type 2 mycoplasma and baculovirus, pseudorabies, swine flu, and foot-and-mouth diseases for pigs, poultry, ruminants, and pets. It also provides diagnostic reagents, combination immunization products, needleless injections, guide products, and diagnostic testing products. The company was formerly known as Inner Mongolia Jinyu Group Co., Ltd. and changed its name to Jinyu Bio-technology Co., Ltd. in December 2015. Jinyu Bio-technology Co., Ltd. was founded in 1992 and is based in Hohhot, China.

ESG Rating Overview

Refinitiv

Overall ESG Rating :

64
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E54S59G80